ETFs & MarketsFreeSchindler and Ipsen Earnings Signal Industrial and Pharma Strength
Strong Q3 performance from Schindler and Ipsen has prompted upward revisions to their 2026 outlooks. These developments highlight resilient demand in the industrial and pharmaceutical sectors, potentially influencing broader market sentiment for sector-specific ETFs.